Does simvastatin block the TNF-α-induced suppression of SERCA2a gene expression and subsequent left ventricular diastolic dysfunction?
Simvastatin blocks the TNF-α-induced suppression of SERCA2a, suggesting a potential therapeutic role for statins in treating inflammation-related diastolic dysfunction.
TNF-α suppresses SERCA2a gene expression via the IKK/IκB/NF-κB pathway and binding of NF-κB to the SERCA2a gene promoter, and its effect is blocked by simvastatin, demonstrating the potential therapeutic effect of statins in treating inflammation-related diastolic dysfunction.
Tsai et al. (Mon,) studied this question.